Skip to main content
Premium Trial:

Request an Annual Quote

Alexandre Mérieux

Alexandre Mérieux has been appointed chairman and CEO of BioMérieux's board, effective immediately. He has served as deputy CEO of the company for the past three years and succeeds Jean-Luc Bélingard, who had been chairman and CEO of BioMérieux since 2010. Mérieux will remain as a director of the company and will continue as vice president of Institut Mérieux. 

Mérieux was corporate vice president of BioMérieux's microbiology unit between 2011 and 2014, after directing the industry unit from 2005 to 2011. He is currently chairman of Mérieux Développement and chairs the board of Mérieux NutriSciences.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.